Target intelligence / Profile preview

WDR4 pseudogene 2 (WDR4P2)

Target: WDR4P2
Molecular classification: Other

Overview

WDR4 pseudogene 2 (WDR4P2) is classified as a pseudogene and does not encode a functional protein or act as a therapeutic receptor, enzyme, transporter, or signaling molecule. There is no evidence for its involvement in cellular pathways, disease processes, or as a drug target. In contrast, the canonical WDR4 gene encodes an essential WD repeat protein with roles in RNA modification and tumorigenesis, but WDR4P2 is a non-functional, non-coding genomic sequence that resembles the active WDR4 gene[5].

Beyond the preview

Go deeper on WDR4 pseudogene 2 (WDR4P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WDR4 pseudogene 2 (WDR4P2).

Explore the full profile